logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
01/11/2025
Jiangsu Ding Tai Pharmaceutical Research Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, with Citigroup and Haitong International as joint sponsors.
Latest
3 m ago
Pfizer accuses Novo Nordisk of planning to evade antitrust scrutiny and "suffocate a new emerging competitor" by sabotaging Pfizer's deal with Metsera.
4 m ago
Pfizer accused Metsera's directors of receiving improper, extensive compensation from Norlund Nord for their "misconduct."
4 m ago
Pfizer: Novo Nordisk's proposal is nothing but a form of old-fashioned bribery to Metsera in order to prevent competition, which harms the interests of both Pfizer and consumers relying on life-changing medications.
9 m ago
Pfizer: Novo Nordisk's acquisition offer for Metsera company is an illegal transaction that cannot be pursued in good faith and with reason.
9 m ago
Brazil's national oil company will increase the average price of aviation fuel for distributors by 1.4% starting on November 1st.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.